Marco Matucci-Cerinic
Overview
Explore the profile of Marco Matucci-Cerinic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
561
Citations
13096
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abraham D, Black C, Denton C, Distler J, Domsic R, Feghali-Bostwick C, et al.
Nat Rev Rheumatol
. 2025 Mar;
PMID: 40032952
No abstract available.
2.
Farina N, Luca G, Peretto G, Bartoli A, Esposito A, Matucci-Cerinic M, et al.
Rev Cardiovasc Med
. 2025 Mar;
26(2):26605.
PMID: 40026523
Cardiac sarcoidosis (CS) is a multifaceted inflammatory disease that affects the heart, leading to complications such as arrhythmias, heart failure, and sudden cardiac death. Endomyocardial biopsy is the diagnostic gold...
3.
Abraham D, Black C, Denton C, Distler J, Domsic R, Feghali-Bostwick C, et al.
Nat Rev Rheumatol
. 2025 Feb;
21(3):174-187.
PMID: 39953141
Systemic sclerosis (SSc) remains a challenging and enigmatic systemic autoimmune disease, owing to its complex pathogenesis, clinical and molecular heterogeneity, and the lack of effective disease-modifying treatments. Despite a century...
4.
Spierings J, Bandini G, Allanore Y, Papa N, Denton C, Distler O, et al.
Semin Arthritis Rheum
. 2025 Feb;
71:152638.
PMID: 39914262
Objective: Autologous stem cell transplantation (AHSCT) is an established treatment in diffuse cutaneous systemic sclerosis (dcSSc). Optimal management of disease progression after AHSCT in dcSSc has not been defined. The...
5.
Denton C, Kowal-Bielecka O, Proudman S, Olesinska M, Worm M, Papa N, et al.
Rheumatology (Oxford)
. 2025 Feb;
PMID: 39909490
Objectives: The primary objective was the safety of subcutaneous immunoglobulin, IgPro20 (Hizentra, CSL Behring) in adults with diffuse cutaneous systemic sclerosis (dcSSc). Secondary objectives included pharmacokinetics and relative bioavailability of...
6.
Bjorkekjaer H, Bruni C, Broch K, Brunborg C, Carreira P, Airo P, et al.
Rheumatology (Oxford)
. 2025 Jan;
PMID: 39878955
Objectives: The 2022 European Society of Cardiology and European Respiratory Society (ESC/ERS) Guidelines for pulmonary arterial hypertension (PAH) recommend risk stratification to optimize management. However, the performance of generic PAH...
7.
Del Galdo F, Lescoat A, Conaghan P, Bertoldo E, colic J, Santiago T, et al.
Ann Rheum Dis
. 2025 Jan;
84(1):29-40.
PMID: 39874231
Objectives: To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. Methods: An international task force was...
8.
Luca G, De Santis M, Batani V, Tonutti A, Campochiaro C, Palmisano A, et al.
Semin Arthritis Rheum
. 2025 Jan;
71:152622.
PMID: 39826307
Background: Primary heart involvement (pHI) is frequent in systemic sclerosis (SSc), and is associated with a poor prognosis. Therapeutic strategies to treat SSc-pHI are not yet defined. Objectives: To evaluate...
9.
Cacciapaglia F, De Angelis R, Ferri C, Bajocchi G, Bellando-Randone S, Bruni C, et al.
J Rheumatol
. 2025 Jan;
PMID: 39814435
Objective: Bosentan (BOS) is approved for treating pulmonary arterial hypertension (PAH) and preventing digital ulcers (DU) in systemic sclerosis (SSc). Our study aimed to evaluate whether BOS prescribed for DU...
10.
Bonomi F, Bandini G, Guiducci S, Matucci-Cerinic M, Bellando Randone S
Rheumatology (Oxford)
. 2024 Dec;
PMID: 39724207
No abstract available.